Thrombocyte migration inhibitory activity of concanavalin-A-stimulated human lymphocytes. In vivo and in vitro modifications by dipyridamole and acetylsalicylic acid.
D000328:Adult; D000368:Aged; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000276:immunology*; D002464:Cell Migration Inhibition; D003208:Concanavalin A / Q000494:pharmacology*; D004176:Dipyridamole / Q000494:pharmacology; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D006801:Humans; D007961:Leukocyte Migration-Inhibitory Factors / Q000096:biosynthesis / Q000494:pharmacology*; D007962:Leukocytes / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology*; D008222:Lymphokines / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged
D007961:Leukocyte Migration-Inhibitory Factors; D008222:Lymphokines; D003208:Concanavalin A; D004176:Dipyridamole; D001241:Aspirin